Neuropeptide-Y family of peptides in the autocrine-paracrine regulation of adrenocortical function

Hormone and Metabolic Research

Volumn 30, Issue 6-7, 1998, Pages 368-373

  Nussdorfer, G G ^a,b   Gottardo, G ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Department of Anatomy ^*  (Italy)

Author keywords

Adrenal Gland; Neuropeptide Y; Pancreatic Polypeptide; Peptide YY; Steroid Secretion

Indexed keywords

NEUROPEPTIDE Y; PANCREAS POLYPEPTIDE;

ADRENAL CORTEX; ADRENAL CORTEX FUNCTION; ARTICLE; BINDING SITE; HORMONAL REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEROID RELEASE;

EID: 0031781549     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978900     Document Type: Article

References (72)

1. Wahlensted C, Reis DJ. Neuropeptide Y-related peptides and their receptors. Are the receptors potential therapeutic drug targets? Annu Rev Pharmacol Toxicol 1993; 32: 309-52
2. Balasubramaniam A. Neuropeptide Y family of hormones: receptor subtypes and antagonists. Peptides 1997; 18: 445-57
3. Colmers WF, Wahlensted C. editors. The Biology of Y Neuropeptide Yand Related Peptides, Totowa, NJ. Humana Press. 1993: 1 -564
4. Taylor IL. Pancreatic polypeptide family: pancreatic polypeptide, neuropeptide Y, and peptide YY. Handb Physiol, Sect 6, Gastrointest Syst 1989; 2: 475-543
5. Larhammer D. Structural diversity of receptors for neuropeptide Y, peptide YY an pancreatic polypeptide. Regul Pept 1996; 65: 165-74
6. Lundberg JM, Modin A, Malmström RE. Recent developments with neuropeptide Y receptor antagonists. Trends Pharmacol Sci 1996; 17: 301-4
7. Malendowicz LK, Markowska A, Zabel M. Neuropeptide Y-related peptides and hypothalamo-pituitary-adrenal axis function. Histol Histopathol 1996; 11: 485-94
8. Nussdorfer GG. Paracrine control of adrenal cortical function by medullary chromaffin cells. Pharmacol Rev 1996; 48: 495-530
9. Heym C. Immunocytochemical correlates of an extrapituitary adrenocortical regulation in man. Histol Histopathol 1997; 12: 567-81
10. Fischer-Colbrie R, Iacangelo A, Eiden LE. Neural and humoral factors separately regulate neuropeptide Y, enkephalin and chromogranin A und B mRNA levels in rat adrenal medulla. Proc Natl Acad Sci USA 1988; 85: 3240-4
11. Schalling M, Seroogy K, Hökfelt T, Chai SY, Hallman H, Persson H, Larhammer D, Erikson A, Terenius L, Graffi J, Massoule J, Goldstein M. Neuropeptide tyrosine in the rat adrenal gland. Immunohistochemical and in situ hybridization studies. Neuroscience 1988; 24: 337-49
12. Higuchi H, Iwasa A, Yoshida H, Miki N. Long lasting increase in neuropeptide Y gene expression in rat adrenal gland with reserpine treatment: positive regulation of transsynaptic activation and membrane depolarization. Mol Pharmacol 1990; 38: 614-23
13. Higuchi H, Iwasa A, Miki N. Rapid decrease in neuropeptide Y gene expression in rat adrenal gland induced by the α2-adrenoreceptor agonist, clonidine. Br J Pharmacol 1991; 103: 1136 -40
14. Schalling M, Franco-Cereda A, Hemsen A, Dagerlind A, Seroogy K, Persson H, Hökfelt T, Lundberg J. Neuropeptide Y and catecholamine synthesizing enzymes and their mRNA in rat sympathetic neurons and adrenal glands: studies on expression, synthesis and axonal transport after pharmacological and experimental manipulations using hybridization techniques and radioimmunoassay. Neuroscience 1991; 41: 753-66
15. Laborie C, Bernet F, Kerckaert JP, Maubert E, Lesage J, Dupouy JP. Regulation of neuropeptide Y and its mRNA by glucocorticoids in the rat adrenal gland. Neuroendocrinology 1995; 62: 601-10
16. Lundberg JM, Hökfelt T, Hemsen A, Theodorsson-Norheim E, Pernow J, Hamberger B, Goldstein M. Neuropeptide Y-like immunoreactivity in adrenaline cells of adrenal medulla and in tumors and plasma of pheochromocytoma patients. Regul Pept 1986; 13: 169-82
17. Majane EA, Alho HJ, Kataoka Y, Lee CH, Yang HYT. Neuropeptide Y in bovine adrenal gland: distribution and characterization. Endocrinology 1985; 117: 1162-8
18. Fischer-Colbrie R, Diez-Guerra J, Emson PC, Winkler H. Bovine chromaffin granules: immunological studies with antisera against neuropeptide Y, (met)enkephalin and bombesin. Neuroscience 1986; 18: 167-74
19. Bastiaensen E, De Block J, De Potter WP. Neuropeptide Y is localized together with enkephalins in adrenergic granules of bovine adrenal medulla. Neuroscience 1988; 65: 679-86
20. Damase-Michel MC, Tavernier G, Giraud P, Montastruc JL, Montastruc P, Tran MA. Effect of clonidine, dihydralazine and splanchnic nerve stimulation on the release of neuropeptide Y, Met-enkephalin and catecholamines from dog adrenal medulla. Naunyn Schmiedebergs Arch Pharmacol 1994; 258: 277-9
21. Damase-Michel MC, Giraud P, Portolan G, Montastruc JL, Montastruc P, Tran MA. Effect of insulin on the release of neuropeptide Y met(5)enkephalin and catecholamines from dog adrenal medulla. Eur J Pharmacol 1994; 258: 277-9
22. Lundberg JM, Fried G, Pernow J, Theodorsson-Norheim E. Corelease of neuropeptide Y and catecholamines upon adrenal activation in the cat. Acta Physiol Scand 1986; 126: 231-8
23. Higuchi H, Yang HYT, Costa E. Age-related bidirectional changes in neuropeptide Y peptides in rat adrenal glands, brain, and blood. J Neurochem 1988; 50: 1879-86
24. Hinson JP, Kapas S. Effect of splanchnic nerve section and compensatory adrenal hypertrophy on rat adrenal neuropeptide content. Regul Pept 1996; 61: 105-9
25. Pelto-Huikko M. Immunohistochemical localization of neuropeptides in the adrenal medulla. J Electr Microsc Tech 1989; 12: 364-79
26. Steiner HJ, Schmidt KW, Fischer-Colbrie R, Sperk G, Winkler H. Co-localization of chromogranin A and B, secretogranin II and neuropeptide Y in chromaffin granules of rat adrenal medulla studied by electron microscopic immunocytochemistry. Histochemistry 1989; 91: 473-7
27. Fernandez-Vivero J, Rodriguez-Sanchez F, Verastegui C, Cordoba-Moriano F, Romero A, De Castro JM. Immunocytochemical distribution of serotonin and neuropeptide Y (NPY) in mouse adrenal gland. Histol Histopathol 1993; 8: 509-20
28. Wolfensberger M, Forssmann WG, Reinecke M. Localization and coexistence of atrial natriuretic peptide (ANP) and neuropeptide Y(NPY) in vertebrate adrenal chromaffin cells immunoreactive to TH, DBH and PNMT. Cell Tissue Res 1995; 280: 267-76
29. Wikström LM, Meister B, Franck J, Fried C. Changes in enkephalin and neuropeptide Y-like immunoreactivity in rabbit chromaffin tissues during perinatal development. Regul Pept 1996; 61: 37-44
30. Varndell IM, Polak JM, Allen JM, Terenghi G, Bloom SR. Neuropeptide tyrosine immunoreactivity in norepinephrine-containing cells and nerves of the mammalian adrenal gland. Endocrinology 1984; 114: 1460-2
31. Kuramoto H, Kondo H, Fujita T. Neuropeptide tyrosine (NPY)-like immunoreactivity in adrenal chormaffin cells and intradrenal nerve fibers of rats. Anat Rec 1986; 214: 321-8
32. Maubert E, Tramu G, Beauvillain JC, Dupouy JP. Co-localization of vasoactive intestinal polypeptide and neuropeptide Y immunoreactivities in the nerve fibers of the rat adrenal gland. Neurosci Lett 1990; 113: 121-6
33. Oomori Y, Okuno S, Fujisawa H, Iuchi H, Ishikawa K, Satoh Y, Ono K. Ganglion cells immunoreactive for catecholamines-synthesizing enzymes, neuropeptide Y and vasoactive intestinal polypeptide in the rat adrenal gland. Cell Tissue Res 1994; 275: 201 -13
34. Maubert E, Dupouy JP, Bernet F. Effect of adrenal demedullation on neuropeptide Y content of the capsule/glomerulosa zone of the rat adrenal gland. Neurosci Lett 1993; 156: 5-8
35. Torda T, Cruciani RA, Saavedra J. Localization neuropeptide Y binding sites in the zona glomerulosa of the bovine adrenal gland. Neuroendocrinology 1988; 48: 207-10
36. Whitcomb DC, Vigna SR, McVey DC, Taylor IL. Localization and characterization of pancreatic polypeptide receptors in rat adrenal glands. Am J Physiol 1992; 262: G532-G6
37. Mazzocchi G, Nussdorfer GG. Neuropeptide Y acutely stimulates rat zona glomerulosa in vivo. Neuropeptides 1987; 9: 257-62
38. Mazzocchi G, Malendowicz LK, Macchi C, Gottardo C, Nussdorfer GG. Further investigations of the effects of neuropeptide-Y (NPY) on the secretion and growth of rat adrenal zona glomerulosa. Neuropeptides 1996; 30: 19-27
39. Hinson JP, Cameron LA, Purbrick A, Kapas S. The role of neuropeptides in the regulation of adrenal zona glomerulosa function: effects of substance P, neuropeptide Y, neurotensin, metenkephalin, leu-enkephalin and corticotropin-releasing hormone on aldosterone secretion in the intact perfused rat adrenal. J Endocrinol 1994; 140: 91-6
40. Neri G, Andreis PG, Nussdorfer GG. Effects of neuropeptide-Y and substance P on the secretory activity of dispersed zona-glomerulosa cells of rat adrenal gland. Neuropeptides 1990; 17: 121-5
41. Hinson JP, Cameron LA, Kapas S. Neuropeptide Y modulates the sensitivity of the rat adrenal cortex to stimulation by ACTH. J Endocrinol 1995; 145: 283-9
42. Hinson JP, Kapas S. Effect of sodium depletion on the response of rat adrenal zona glomerulosa cells to stimulation by neuropeptides: actions of vasoactive intestinal peptide, enkephalin, substance P, neuropeptide Y and corticotrophin-releasing hormone. J Endocrinol 1995; 146: 209-14
43. 18-36) and peptide YY (PYY) on rat adrenal capsule/zona glomerulosa. Regul Pept 1994; 52: 187-94
44. Bernet F, Bernard J, Laborie C, Montel V, Maubert E, Dopouy JP. Neuropeptide Y (NPY)-and vasoactive intestinal peptide (VIP)-induced aldosterone secretion by rat capsule/glomerulosa zone could be mediated by catecholamines via β1 adrenergic receptors. Neurosci Lett 1994; 166: 109-12
45. Di Maggio DA, Farah JM Jr, Westfall TC. Effects of differentiation on neuropeptide Y receptors and responses in rat pheochromocytoma cells. Endocrinology 1994; 134: 719-27
46. Hong N, Li S, Fournier A, Saint-Pierre S, Pelletier G. Role of neuropeptide Y in the regulation of tyrosine hydroxylase gene expression in rat adrenal glands. Neuroendocrinology 1995; 61: 85-8
47. Neri G, Andreis PG, Malendowicz LK, Nussdorfer GG. Acute action of polypeptide YY (PYY) on rat adrenocortical cells: in vivo versus in vitro effects. Neuropeptides 1991; 19: 73-6
48. Andreis PG, Tortorella C, Nussdorfer GG. Pancreatic polypeptide stimulates corticosterone secretion by isolated rat adrenocortical cells. Life Sci 1993; 53: 1353-6
49. Mazzocchi G, Malendowicz LK, Gottardo G, Meneghelli V, Nussdorfer GG. Pancreatic polypeptide enhances plasma glucocorticoid concentration in rats: possible role in hypoglycemic stress. Life Sci 1995: 56: 595-600
50. Wahlstedt C, Regunathan S, Reis DJ. Identification of cultured cells selectively expressing Y1-Y2-or Y3-type receptors for neuropeptide Y/peptide YY. Life Sci 1991: 50: PL7-PL12
51. Lesniewska B, Nowak M, Miskowiak B, Nussdorfer GG, Malendowicz LK. Long-term effects of neuropeptide Y on the rat adrenal cortex Neuropeptides 1990: 16: 9-13
52. Hinson JP, Purbrick A, Cameron LA, Kapas S. The role of neuropeptides in the regulation of adrenal zona fasciculata-reticularis function: effects of vasoactive intestinal polypeptide, substance P, neuropeptide Y, met-and leu-enkephalin and neurotensin on corticosterone secretion in the intact perfused rat adrenal gland in situ. Neuropeptides 1994; 26: 391-8
53. Hinson JP, Purbrick A, Cameron LA, Kapas S. The role of neuropeptides in the regulation of adrenal vascular tone: effects of vasoactive intestinal polypeptide, substance P, neuropeptide Y, neurotensin, met-enkephalin and leu-enkephalin on perfusion medium flow rate in the intact perfused rat adrenal. Regul Pept 1994; 51: 55-61
54. Vinson GP, Hinson JP. Blood flow and hormone secretion in the adrenal gland. In: James VTH. editor. The Adrenal Gland. New York: Raven Press. 1992: 71-86
55. Malendowicz LK, Lesniewska B, Miskowiak B. Neuropeptide-Y inhibits corticosterone secretion by isolated rat adrenocortical cells. Experientia 1990; 46: 721-2
56. Rebuffat P, Malendowicz LK, Belloni AS, Mazzocchi G, Nussdorfer GG: Long-term stimulatory effect of neuropeptide-Y on the growth and steroidogenic capacity of rat adrenal zona glomerulosa. Neuropeptides 1988; 11: 133-6
57. Nussdorfer GG. Cytophysiology of the adrenal cortex. Int Rev Cytol 1986; 98: 1-405
58. Allen JM, Bircham PMM, Bloom SR, Edwards AV. Release of neuropeptide Y in response to splanchnic nerve stimulation in the conscious calf. London: J Physiol 1984; 354: 401-6
59. Briand R, Yamaguchi N, Gagne J, Kimura T, Farley L, Foucart S, Nadeau R, De Champlain J. Corelease of neuropeptide Y-like immunoreactivity with catecholamines from the adrenal gland during splanchnic nerve stimulation in anesthetized dogs. Can J Physiol Pharmacol 1990; 68: 363-9
60. Shimoda K, Shen GH, Pfeiffer RF, McComb RD, Yang HYT. Antiserum against neuropeptide Y enhances the nicotine-mediated release of catecholamines from cultured rat adrenal chromaffin cells. Neurochem Int 1993; 23: 71-7
61. Lundberg JM, Al-Saffar A, Saria A, Theodorsson-Norheim E. Reserpine-induced depletion of neuropeptide Y from cardiovascular nerves and adrenal gland due to enhanced release. Naunyn Schmiedebergs Arch Pharmacol 1986; 332: 163-8
62. Nagata M, Franco-Cereda A, Saria A, Amann R, Lundberg JM. Reserpine-induced depletion of neuropeptide Y in the guinea-pig: tissue-specific effects and mechanism of action. J Auton Nerv Syst 1987; 20: 257-63
63. Lundberg JM, Martinsson A, Hemsen A, Theodorsson-Norheim E, Svedenhag J, Ekblom B, Hjemdahl P. Co-release of neuropeptide-Y and catecholamines during physical exercise in man. Biochem Biophys Res Commun 1985; 133: 30-6
64. Higuchi H, Iwasa A, Yokokawa K. High levels of expression of neuropeptide Y mRNA in human pheochromocytomas. Clin Exp Pharmacol Physiol 1994; 21: 359-65
65. Senanayake P deS, Denker J, Bravo EL, Graham RM. Production, characterization, and expression of neuropeptide Y by human pheochromocytomas. J Clin Invest 1995; 96: 2503-9
66. 8, neuropeptide Y and somatostatin in human adrenal medulla and pheochromocytomas. Peptides 1987; 8: 77-87
67. Grouzmann E, Werffeli-George P, Fathi M, Burnier M, Waeber B, Waeber G. Angiotensin-II mediates norepinephrine and neuropeptide-Y secretion in a human pheochromocytoma. J Clin Endocrinol Metab 1994; 79: 1852-6
68. Michel MC, Rascher W. Neuropeptide Y: a possible role in hypertension? J Hypertens 1995; 13: 385-95
69. Gordon RD, Bachmann AW, Klem SA, Tunny TJ, Stowasser M, Storie WJ, Rutherford JG. An association of primary aldosteronism and adrenaline-secreting pheochromocytoma. Clin Exp Pharmacol Physiol 1994; 21: 219-22
70. Tan GH, Carney JA, Grant CS, Young WF Jr. Coexistence of bilateral pheochromocytoma and idiopathic hyperaldosteronism. Clin Endocrinol 1996; 44: 603-9
71. Higuchi H, Nakano H, Iwasa A. Decrease in prepro-neuropeptide Y gene expression in the rat adrenal gland and cerebral cortex of spontaneously hypertensive rats. Neuropeptides 1993; 25: 343 -9
72. Higuchi H, Yokokawa K, Iwasa A, Yoshida, Miki N. Age-dependent increase in neuropeptide Y gene expression in rat adrenal gland and specific brain areas. J Neurochem 1991; 57: 1840-7